Schedule 13D ownership disclosure
UROVANT SCIENCES LTD
Security class unavailable · CUSIP: G9381B108
Event date: 2019-01-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 22,703,669
- Percent of class
- 75.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-19-000003
- Form type
- SC 13D
- Filer
- Urovant Sciences Ltd.
- CIK
- CIK 1740547
- Filed
- Jan 03, 2019
- Reporting period
- Jan 01, 2019
- Description
- Schedule 13D beneficial ownership